Equities

Chordate Medical Holding AB (publ)

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Chordate Medical Holding AB (publ)

Actions
  • Price (EUR)0.0628
  • Today's Change-0.006 / -8.19%
  • Shares traded4.70k
  • 1 Year change-93.22%
  • Beta1.5955
Data delayed at least 15 minutes, as of Feb 13 2026 07:27 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Chordate Medical Holding AB (publ) is a medical technology company based in Sweden. The Company develops treatment method through nerve stimulation for chronic nasal congestion. The Company’s headquartered is located in Kista, Sweden.

  • Revenue in SEK (TTM)993.34k
  • Net income in SEK-25.16m
  • Incorporated2014
  • Employees3.00
  • Location
    Chordate Medical Holding AB (publ)Kistagangen 20 BKISTA 164 40SwedenSWE
  • Phone+46 840011586
  • Websitehttps://www.chordate.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.